A recent study demonstrated that casticin treatment induced apoptosis in breast cancer cells via the activation of forkhead box O3 (FOXO3a) and the repression of forkhead box protein M1 (FOXM1) [18]. The gene discussed is FOXO3; the disease is breast carcinoma.